North Dakota State Investment Board Invests $1.45 Million in Axon Enterprise, Inc $AXON

Posted by Brian Himes on May 20th, 2026

North Dakota State Investment Board acquired a new position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 2,555 shares of the biotechnology company’s stock, valued at approximately $1,451,000.

A number of other hedge funds have also recently made changes to their positions in the business. Elyxium Wealth LLC bought a new position in shares of Axon Enterprise in the fourth quarter worth about $49,000. Abacus Wealth Partners LLC bought a new position in shares of Axon Enterprise in the fourth quarter worth about $299,000. iA Global Asset Management Inc. boosted its stake in shares of Axon Enterprise by 7.9% in the fourth quarter. iA Global Asset Management Inc. now owns 9,809 shares of the biotechnology company’s stock worth $5,571,000 after acquiring an additional 719 shares during the period. Beese Fulmer Investment Management Inc. boosted its stake in shares of Axon Enterprise by 12.9% in the fourth quarter. Beese Fulmer Investment Management Inc. now owns 4,591 shares of the biotechnology company’s stock worth $2,607,000 after acquiring an additional 526 shares during the period. Finally, Canada Post Corp Registered Pension Plan lifted its position in shares of Axon Enterprise by 28.8% in the fourth quarter. Canada Post Corp Registered Pension Plan now owns 1,880 shares of the biotechnology company’s stock worth $1,068,000 after buying an additional 420 shares in the last quarter. Institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. Craig Hallum reiterated a “buy” rating and issued a $820.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 25th. Barclays decreased their target price on Axon Enterprise from $682.00 to $523.00 and set an “overweight” rating on the stock in a research report on Friday, May 8th. Wall Street Zen upgraded Axon Enterprise from a “sell” rating to a “hold” rating in a research report on Saturday, February 28th. William Blair reiterated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, February 3rd. Finally, Piper Sandler decreased their target price on Axon Enterprise from $690.00 to $674.00 and set an “overweight” rating on the stock in a research report on Thursday, May 7th. Sixteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $712.75.

Get Our Latest Research Report on Axon Enterprise

Insider Activity

In related news, CAO Jennifer H. Mak sold 1,500 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $573.45, for a total value of $860,175.00. Following the completion of the transaction, the chief accounting officer owned 12,240 shares in the company, valued at $7,019,028. This trade represents a 10.92% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Jeri Williams sold 157 shares of the firm’s stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $490.00, for a total value of $76,930.00. Following the completion of the transaction, the director owned 1,159 shares of the company’s stock, valued at $567,910. This trade represents a 11.93% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 13,855 shares of company stock worth $7,109,828. Company insiders own 4.20% of the company’s stock.

Axon Enterprise Stock Down 1.8%

Shares of NASDAQ:AXON opened at $392.34 on Wednesday. Axon Enterprise, Inc has a 52-week low of $339.01 and a 52-week high of $885.91. The stock has a market cap of $31.62 billion, a P/E ratio of 157.57, a price-to-earnings-growth ratio of 9.39 and a beta of 1.44. The business’s 50 day moving average is $425.17 and its 200 day moving average is $508.74. The company has a quick ratio of 1.93, a current ratio of 2.27 and a debt-to-equity ratio of 0.49.

Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its quarterly earnings data on Wednesday, May 6th. The biotechnology company reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.60 by $0.01. Axon Enterprise had a return on equity of 3.78% and a net margin of 6.90%.The company had revenue of $807.35 million for the quarter, compared to analysts’ expectations of $778.91 million. During the same quarter in the prior year, the firm earned $1.47 earnings per share. Axon Enterprise’s revenue was up 33.7% compared to the same quarter last year. Sell-side analysts predict that Axon Enterprise, Inc will post 1.41 EPS for the current year.

About Axon Enterprise

(Free Report)

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.